Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2025-12-25 @ 2:03 AM
NCT ID:
NCT01382160
Eligibility Criteria:
Inclusion Criteria:
* RA according to the American College of Rheumatology (ACR) 1987 criteria
* Treatment with Adalimumab has been chosen by the physician / patient
* Treatment given in accordance to the SPC
* Stable Disease modifying anti rheumatic drugs (DMARDs) and glucocorticoids 4 weeks before enrollment and during the study period.
* Signed consent
Exclusion Criteria:
* more than one previous treatment with anti TNF-alpha
* Past history of malignancy, AIDS
* Pregnancy
* Change in DMARDS or glucocorticoid dose 4 weeks before entering the study
* Active or latent tuberculosis, other active infections
* Surgery scheduled during the study period
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01382160
Study Brief:
Protocol Section:
NCT01382160